Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pagnucco

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Haematologica|November 1, 1989
Secondary lymphomas: a review on lymphoproliferative diseases arising in immunocompromised hosts: prevalence, clinical features and pathogenetic mechanismsE Brusamolino, G Pagnucco, C Bernasconi
European Journal of Haematology. Supplementum|January 1, 1989
Plasma cell leukemia: a report on 15 patientsC Bernasconi, G Castelli, G Pagnucco, et al.
Minerva Medica|July 1, 1993
[The diagnosis of non-Hodgkin's lymphoma in a patient with Marfan's syndrome]A Corso, G Pagnucco, E Morra, et al.
Leukemia|January 1, 1991
Burkitt's lymphoma/leukemia: a clinicopathologic study on 24 adult patientsC Bernasconi, E Brusamolino, G Pagnucco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1990
Lymphoblastic lymphoma in adult patients: clinicopathological features and response to intensive multiagent chemotherapy analogous to that used in acute lymphoblastic leukemiaC Bernasconi, E Brusamolino, M Lazzarino, et al.
Haematologica|May 21, 1998
Efficacy of a combination of idarubicin, etoposide and intermediate-dose cytosine arabinoside as salvage therapy in relapsing or resistant unfavorable lymphomaE Brusamolino, F Passamonti, G Pagnucco, et al.
Haematologica|July 1, 1990
CAV chemotherapy (CCNU, melphalan, etoposide) as salvage treatment for relapsing or resistant Hodgkin's diseaseE Brusamolino, G Castelli, G Pagnucco, et al.
Tumori|June 30, 1985
Immunoblastic lymphoma: a clinicopathologic study with emphasis on the cases intervening during or following other disordersE Brusamolino, U Magrini, G Castelli, et al.
British Journal of Haematology|June 1, 1997
Treatment with recombinant human erythropoietin (rHuEpo) in a patient with paroxysmal nocturnal haemoglobinuria: evaluation of membrane proteins CD55 and CD59 with cytofluorometric assayC Astori, M Bonfichi, G Pagnucco, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|August 7, 1998
Unilateral retinal vasculitis associated with hairy cell leukaemia: immunogenetic studyA Di Maria, C Redaelli, A Canevari, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Haematologica|November 1, 1989
Secondary lymphomas: a review on lymphoproliferative diseases arising in immunocompromised hosts: prevalence, clinical features and pathogenetic mechanismsE Brusamolino, G Pagnucco, C Bernasconi
European Journal of Haematology. Supplementum|January 1, 1989
Plasma cell leukemia: a report on 15 patientsC Bernasconi, G Castelli, G Pagnucco, et al.
Minerva Medica|July 1, 1993
[The diagnosis of non-Hodgkin's lymphoma in a patient with Marfan's syndrome]A Corso, G Pagnucco, E Morra, et al.
Leukemia|January 1, 1991
Burkitt's lymphoma/leukemia: a clinicopathologic study on 24 adult patientsC Bernasconi, E Brusamolino, G Pagnucco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1990
Lymphoblastic lymphoma in adult patients: clinicopathological features and response to intensive multiagent chemotherapy analogous to that used in acute lymphoblastic leukemiaC Bernasconi, E Brusamolino, M Lazzarino, et al.
Haematologica|May 21, 1998
Efficacy of a combination of idarubicin, etoposide and intermediate-dose cytosine arabinoside as salvage therapy in relapsing or resistant unfavorable lymphomaE Brusamolino, F Passamonti, G Pagnucco, et al.
Haematologica|July 1, 1990
CAV chemotherapy (CCNU, melphalan, etoposide) as salvage treatment for relapsing or resistant Hodgkin's diseaseE Brusamolino, G Castelli, G Pagnucco, et al.
Tumori|June 30, 1985
Immunoblastic lymphoma: a clinicopathologic study with emphasis on the cases intervening during or following other disordersE Brusamolino, U Magrini, G Castelli, et al.
British Journal of Haematology|June 1, 1997
Treatment with recombinant human erythropoietin (rHuEpo) in a patient with paroxysmal nocturnal haemoglobinuria: evaluation of membrane proteins CD55 and CD59 with cytofluorometric assayC Astori, M Bonfichi, G Pagnucco, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|August 7, 1998
Unilateral retinal vasculitis associated with hairy cell leukaemia: immunogenetic studyA Di Maria, C Redaelli, A Canevari, et al.
Pageof 6